Focused on innovating genetic analysis tools for the research and diagnostics market.
The first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.
Inscripta offers the world’s first benchtop platform for scalable Digital Genome Engineering to address the current challenges and limitations of gene editing.
Harnessing the regulatory genome to create next-generation molecular therapies.
10X Genomics provides an innovative genomics platform that delivers additional genetic information by dramatically upgrading the capabilities of existing short read sequencers.
Targeted Genetics is a biotech company developing gene-based therapies to prevent or treat diseases such as HIV, Cystic Fibrosis, Rheumatoid Arthritis, and severe heart failure.
Ariosa Diagnostics has developed, and is currently commercializing, a proprietary non invasive prenatal diagnostic test for genetic abnormalities.
Symyx Technologies develops and applies proprietary combinatorial methodologies to discover and develop new materials for the electronics and chemical industries.
PerSeptive BioSystems produced chromatographic media and hardware systems for production-scale separation, purification and analysis of biomolecules.
Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.